Mass Spectrometry
AccelBio offers unique proteomics and metabolomics
services to address key issues in drug and biomarker
discovery.
The mass spectrometry platform can support target validation on the functional protein level.
Likewise, it enables unbiased mode of action studies, the identification of specific
pharmacodynamic and pharmacokinetics readouts and lead compound prioritization
according to cellular activity profiles.
For further info, check our catalogue:
https://accelbio.pt/wp-content/uploads/2024/01/accelbio-capabilities-catalogue-interactive.pdf